鹭燕医药：“鹭燕现代中药生产项目”一期建设完成并获新证

Core Viewpoint - The company has made significant progress in its "Luyan Modern Traditional Chinese Medicine Production Project," with the first phase of construction completed, enhancing its production capacity and market competitiveness [1] Group 1: Project Development - The company agreed to establish the "Luyan Modern Traditional Chinese Medicine Production Project" through its subsidiary, Bozhou Traditional Chinese Medicine Processing Plant, in November 2020 [1] - The first phase of the project has completed the construction of production and office facilities, covering an area of approximately 180,000 square meters [1] - The Anhui Provincial Drug Administration has approved the expansion of the production scope and address for the Bozhou Traditional Chinese Medicine Processing Plant [1] Group 2: Regulatory Approval - The plant obtained a new "Drug Production License" on January 21, which is crucial for the company's operations [1] - The completion of the first phase is expected to secure the company's production capacity for traditional Chinese medicine pieces [1] - This development is anticipated to assist in market expansion and enhance the company's competitiveness [1]